(Q33888146)

29 July 2017

1 reference

title

Treatment of diabetes in patients with severe obesity (English)

1 reference

29 July 2017

0 references

Scheen AJ

1

1 reference

29 July 2017

1 March 2000

1 reference

Biomedicine and Pharmacotherapy

29 July 2017

1 reference

29 July 2017

54

1 reference

29 July 2017

74-79

1 reference

29 July 2017

2

1 reference

The pharmacological treatment of hyperglycemia in NIDDM. American Diabetes Association

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

1 reference

7 January 2021

Promoting weight loss in type II diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

An overview of metformin in the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

1 reference

7 January 2021

Lifestyle modifications for diabetes management

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Treating obesity in type 2 diabetes. Calories, composition, and control

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

1 reference

7 January 2021

Benefits and limitations of very-low-calorie diet therapy in obese NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Stepwise and combination drug therapy for the treatment of NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

The prevention and treatment of obesity. Application to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

1 reference

7 January 2021

Sibutramine. A review of its contribution to the management of obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Is Type II Diabetes Mellitus (NIDDM) a Surgical Disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Pharmacologic induction of weight loss to treat type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Oral antidiabetic agents. A guide to selection

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Pharmacological treatment of obesity: present status

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Biliopancreatic diversion

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

1 reference

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2800%2988855-1

7 January 2021

10.1016/S0753-3322(00)88855-1

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10759290